The ARF6 Knockout A-549 Polyclonal Cells represent a targeted loss-of-function model generated through CRISPR/Cas9-mediated gene disruption of the ARF6 locus in A-549 human lung adenocarcinoma cells. This pooled polyclonal population, derived without single-cell cloning, provides a heterogeneous knockout background ideal for studying ARF6-dependent cellular phenotypes in a physiologically relevant cancer context. By abrogating ARF6 expression, researchers can interrogate the consequences of disrupted membrane trafficking and cytoskeletal dynamics on tumor cell behavior.
The host A-549 cell line, established from the lung carcinoma of a 58-year-old Caucasian male, is a widely utilized model for non-small cell lung cancer (NSCLC) research. These adherent epithelial cells exhibit alveolar type II pneumocyte characteristics and are extensively characterized for their growth properties, signaling networks, and metastatic potential. Their genetic background and reproducible culture conditions make them a robust platform for evaluating gene function in lung adenocarcinoma.
ARF6 encodes a small GTPase that cycles between GDP- and GTP-bound states, governing endosomal trafficking and actin cytoskeleton reorganization. Its activation is promoted by the GEFs ARNO/CYTH2 and EFA6 downstream of EGFR stimulation and integrin engagement. Active ARF6-GTP interacts with a network of effectors and scaffold proteins including ACAP1, ACAP2, ASAP1, AMAP1, JIP3, JIP4, and Sec10, and it stimulates phospholipase D (PLD) and phosphatidylinositol 4-phosphate 5-kinase (PI4P5K) to produce phosphatidylinositol 4,5-bisphosphate (PIP2). This lipid messenger activates Rac1, driving actin polymerization via the N-WASP/Arp2/3 complex, while also regulating integrin ??v??3 recycling and E-cadherin internalization. Consequently, ARF6 links integrin signaling, receptor tyrosine kinase recycling, Wnt signaling, and E-cadherin trafficking.
In A-549 lung adenocarcinoma cells, ARF6 disruption markedly compromises the trafficking machinery essential for cell-matrix adhesion, migration, and invasion??processes central to metastatic progression. The loss of ARF6-dependent integrin recycling attenuates Rac1-driven actin remodeling, impairing lamellipodia formation and directional motility. Moreover, defective E-cadherin trafficking may alter cell-cell contacts, further facilitating a migratory phenotype. This knockout model thus provides a valuable system for dissecting the molecular underpinnings of NSCLC invasion and for assessing the therapeutic potential of targeting ARF6-mediated pathways.
Typical applications include mechanistic studies of ARF6 signaling in lung cancer metastasis, live-cell imaging of membrane trafficking dynamics, and screening for small molecule inhibitors targeting the ARF6 network. Compatible assays are western blotting, RT-qPCR, immunofluorescence, Transwell migration/invasion, cell adhesion, integrin recycling, Rac1-GTP pull-down activation, and drug sensitivity profiling. This tool supports academic and pharmaceutical research into ARF6 biology. For further technical details, please contact Ascent Research.
